White House to announce new drug pricing deals with biotechs, Bloomberg News reports

Trump’s administration plans to announce a new round of drug-pricing agreements with midsize biotech companies on Monday, according to Bloomberg. The article provides limited specifics, but the policy initiative could affect pricing economics and margins for participating companies. Net impact is likely moderate and depends on agreement terms.